Natallie Rocha


Phone: 858-277-6359 Extension: 3120

Recent Stories

Palomar Health CEO Honored

HEALTHCARE: Hansen Wins Leadership Award

Diane Hansen, president and CEO of Palomar Health won the CEO of the Year award from The Association of California Healthcare Districts for her leadership and transformation of the North County healthcare district.

Tease photo

INOVIO Advances COVID-19 Vaccine Trials

BIOTECH: Co. Moves Forward in Mexico, Brazil and the Philippines

INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company designing DNA medicines, received approval from Mexico’s national health regulatory agency to advance its COVID-19 vaccine candidate to Phase 3 clinical trials.

Tease photo

Cue Health Goes Public

BIOTECH: IPO Raises $200M

Cue Health rang the opening bell on the Nasdaq to celebrate its first day as a publicly traded company on Sept. 24. The San Diego-based health technology company, which makes digital diagnostic testing solutions including a COVID-19 molecular test, raised $200 million through its IPO.

Tease photo

Endeavor BioMedicines Tackles Root Cause of Diseases

MEDICINE: Growing Co. Inks Licensing Deal with Salk Institute and Sanford Burnham Prebys

Endeavor BioMedicines, a clinical-stage precision medicine company, signed an exclusive licensing deal with the Salk Institute for Biological Studies and Sanford Burnham Prebys for a ULK1/2 inhibitor program to broaden the company’s precision oncology pipeline.

Agena Acquired for $300M

BIOTECH: Co. to Remain in S.D.

San Diego-based Agena Bioscience, Inc. agreed to be acquired by Mesa Laboratories, Inc. (NASDAQ:MLAB) for a purchase price of $300 million.

Cue Health Enters the Public Market

Company valuation of $2.3 billion at IPO

Tease photo

Replicate Bioscience Exits Stealth Mode

BIOTECH: Firm Invests in RNA Treatments

Replicate Bioscience, a startup developing a pipeline of RNA-based treatments, exited stealth mode on Sept. 8 with $40 million in Series A backing its launch.

Jumpcode to Help Sequence COVID-19

BIOTECH: Co. Partners With Research Institute

Jumpcode Genomics, a local genome technology company, has partnered with the Translational Genomics Research Institute (TGen) to help sequence and examine the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19.

Tease photo

Cue Health to Sell 12 Million Shares in IPO

Cue Health will offer 12.5 million common shares for a range of $15 to $17 per share, according to its amended IPO.

Advanced BioMatrix Acquired for $15 Million

BIOTECH: San Diego Co. Joins BICO’s Bioprinting Business

Advanced BioMatrix, a San Diego biotech that creates products for 3D applications including cell cultivation, cell assays and bioprinting, was acquired by BICO Group AB (STO: BICO) for approximately $15 million.

More stories >>